Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced its 2016 annual financial results.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2017/03/QUANTUM_PR_Annual-results-2016_30032017_VDEF_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
